ELDN
NASDAQ · Biotechnology
Eledon Pharmaceuticals Inc
$2.83
-0.13 (-4.39%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+327.2% upside
Low Target
$9.42
Average Target
$12.09
High Target
$15.53
Current Price
$2.83
Current
$2.83
$2.83
Target
$12.09
$12.09
$9.42
$12.09 avg
$15.53
Scenario Analysis
Bear Case
$9.42
232.9%
Low target
Base Case
$12.09
+327.2%
Avg target
Bull Case
$15.53
+448.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.60
-38.5% from high
52-Week Low
$1.35
+109.6% from low
Target vs 52W High
$12.09
+162.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.8% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.0% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +158.5% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.0% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -13.0% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.7% |